Furthermore, research conducted by Ye XZ and colleagues has indicated that knockdown of TGFBR2 (Transforming Growth Factor Beta Receptor 2) diminishes the invasive potential of glioma cells (158). The gene discussed is TGFBR2; the disease is central nervous system cancer.